About Us:

Zagros Pharmed Pars Pharmaceutical Company (Public Joint Stock) started its operations more than forty years ago, during the imposed war in 1983, with the participation of specialized and dedicated personnel in Borujerd city, covering an area of 56,000 square meters under the name “Damloran.”

In 2003, to synergize with Razak Pharmaceutical Laboratories in the field of specialized veterinary drug production, it continued its activities under the name “Damloran Razak Pharmaceutical” after their merger.

In 2012, with the inauguration of the sterile drug production line in both human and veterinary sectors, inspired by the proud peaks of the Zagros mountain range, the company’s name was changed to “Zagros Pharmed Pars.”

This company was founded with the financial support of the Social Security Investment Company (Shasta) and is a subsidiary of the Pharmaceutical Investment Company (TPICO).

“Zagros Pharmed Pars Pharmaceutical Company, in collaboration with reputable international pharmaceutical organizations and adhering to Good Manufacturing Practices (GMP), produces over 150 products (including human and veterinary medicines) in injectable and oral forms.”